Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fuji
Medtronic
Deloitte
US Department of Justice
US Army
Accenture
Healthtrust
Federal Trade Commission
McKinsey

Generated: June 19, 2018

DrugPatentWatch Database Preview

DEXTROSE 30% IN PLASTIC CONTAINER Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

When do Dextrose 30% In Plastic Container patents expire, and when can generic versions of Dextrose 30% In Plastic Container launch?

Dextrose 30% In Plastic Container is a drug marketed by Baxter Hlthcare and Icu Medical Inc and is included in two NDAs.

The generic ingredient in DEXTROSE 30% IN PLASTIC CONTAINER is dextrose. There are eight drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the dextrose profile page.
Summary for DEXTROSE 30% IN PLASTIC CONTAINER
Drug patent expirations by year for DEXTROSE 30% IN PLASTIC CONTAINER

US Patents and Regulatory Information for DEXTROSE 30% IN PLASTIC CONTAINER

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Baxter Hlthcare DEXTROSE 30% IN PLASTIC CONTAINER dextrose INJECTABLE;INJECTION 017521-003 Approved Prior to Jan 1, 1982 AP RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Icu Medical Inc DEXTROSE 30% IN PLASTIC CONTAINER dextrose INJECTABLE;INJECTION 019345-001 Jan 26, 1985 AP RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cipla
Covington
AstraZeneca
Baxter
QuintilesIMS
Harvard Business School
Express Scripts
Colorcon
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.